Press release
Cancer Vaccines Market Size to Grow Value of $7.30 billion by 2027, at CAGR of 12.6% With Top Companies UbiVac, and Vaccinogen, Inc
Cancer Vaccines Market
The global cancer vaccines market industry was pegged at $ 4.18 billion in 2019 and is expected to reach $7.30 billion by 2027, registering a CAGR of 12.6% from 2020 to 2027.
Download Detailed COVID-19 Impact Sample Report at @ https://www.alliedmarketresearch.com/request-for-customization/1453?reqfor=covid
COVID-19 Scenario:
• The COVID-19 outbreak has affected the manufacturing of cancer vaccines owing to global shutdown.
• The rise in number of healthcare workers falling ill in the wake of the COVID-19 pandemic, resulted in shortage of supply.
• Furthermore, the supply chain disruptions have equally disturbed the production cycle, causing shortage of raw materials.
• Moreover, productions facilities have increased in the past few months, with the relaxations issued by several government bodies.
Key determinants of the market-
Rise in prevalence of human papilloma virus (HPV) cancer, increase in administration of prophylactic cancer vaccines, surge in development of new cancer vaccines, and launch and approval of new cancer vaccines propel the global cancer vaccines market. However, high cost and longer timelines required for development of cancer vaccines impede the market growth. On the other hand, high growth prospects in emerging markets are expected to offer innumerable opportunities to the market.
Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/1453
The recombinant cancer segment to dominate the market-
Based on technology, the recombinant cancer vaccines segment held the largest share in 2019, contributing to more than four-fifths of the global cancer vaccines market. This is due to increase in utilization of recombinant vaccines, and recombinant cancer vaccine as most efficient alternative to traditional vaccines in the prevention of various human diseases. Furthermore, rise in adoption of these medicines due to rapid elimination of risk of active infection fuels the growth. However, the dendritic cells cancer vaccines segment is projected to register the fastest CAGR of 15.4% during the forecast period. This is owing to easy availability of DC cells for the development of cancer vaccines, as human DCs easily can be produced from monocytes isolated from peripheral blood.
The preventative cancer vaccines segment to lead the trail throughout 2027-
Based on type, the preventative cancer vaccines segment dominated the global cancer vaccines market in 2019, contributing to 89% of the market. This is due to increase in research activities on the potential of preventive cancer vaccines and rise in awareness among people regarding the benefits of the preventive cancer vaccinations. However, the therapeutic cancer vaccines segment is anticipated to portray the fastest CAGR of 14.7% during the forecast period. The therapeutic cancer vaccines represent a viable option for active immunotherapy of cancers that aim to cure late stage disease by strengthening the patient's immune system, which drives the segment growth.
North America to held lion's share-
Based on region, North America held the largest share in 2019, contributing to more than two-fifths of the global cancer vaccines market. This is owing to increase in prevalence of cancer patients, technological advancements in cancer vaccines products, and surge in conduction of clinical trials of new cancer vaccines to eradicate various types of cancers, in this province. On the other hand, the market across Asia-Pacific is projected to register a CAGR of 15.0 during the study period. This is owing to rise in adoption of cancer vaccines treatment medication, increase in number of cancer patients, and rise in demand for cancer vaccines in Asia-Pacific region.
To know more about the report, visit the website at @ https://www.alliedmarketresearch.com/cancer-vaccines-market
The major companies profiled Are:
Advaxis Inc., Amgen Inc., Dynavax Technologies Corporation, Generex Biotechnology Corporation, GlaxoSmithKline plc (GSK), Immunocellular Therapeutics, Ltd, Merck & Co., Inc., Sanpower Group Co. Ltd. (Dendereon Corporation), UbiVac, and Vaccinogen, Inc.
The other key players Are:
Gritstone Oncology, PaxVax Corporation., Bavarian Nordic, Bharat Biotech., VBI Vaccines Inc., Novavax, Inc., Dynavax Technologies Corporation, Immunomic Therapeutics, Inc., Gamma Vaccines Pty Limited, Sinovac Biotech Ltd., Galena Biopharma, Emergent Biosolutions, Prokarium, and ImmunoBiology Ltd.
Similar Reports:
U.S. Topical Pain Relief Market : https://www.einpresswire.com/article/528297417/pharma-giant-expects-to-u-s-topical-pain-relief-market-lineup-to-be-its-top-seller-this-year
Companion Diagnostic Market : https://www.einnews.com/pr_news/528393367/companion-diagnostics-market-growth-in-the-united-states-has-risen-dramatically-industry-forecast-2019-2026
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
About Us:
Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Vaccines Market Size to Grow Value of $7.30 billion by 2027, at CAGR of 12.6% With Top Companies UbiVac, and Vaccinogen, Inc here
News-ID: 2251466 • Views: …
More Releases from Allied Market Research
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collect…
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth…
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict…
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in…
More Releases for Vaccines
Vaccines Market: Information by Type (Monovalent Vaccines, Multivalent Vaccines) …
Till date, vaccines have majorly contributed to eradicating several severe diseases—smallpox and polio—from the face of the earth. During 1980–90, around millions of people died due to smallpox. Moreover, after the introduction of a worldwide End Polio Campaign, the number of polio cases has reduced to 407 in 2013 from 350,000 in 1988, the CDC.
Global vaccines market was valued at USD 30.2 billion in 2018 and is expected to…
Global Pet Vaccine Market By Type (Attenuated Live Vaccines, Conjugate Vaccines, …
The Global Pet Vaccine Market 2020 report implement in-depth research of the industry with a focus on the current market trends future prospects. The Global Pet Vaccine Market report aims to provide an overview of Pet Vaccine Market players with detailed market segmentation by product, application and geographical region. It also provides market share and size, revenue forecast, growth opportunity. The most recent trending report Worldwide Pet Vaccine Market Economy…
Animal Vaccines Market Report 2018: Segmentation by Product (Attenuated Vaccines …
Global Animal Vaccines market research report provides company profile for Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, Anicon Labor GmbH, Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, Arko Laboratories, Ltd. Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in…
Vaccines & Vaccination Market Report 2018: Segmentation by Type (Subunit vaccine …
Global Vaccines & Vaccination market research report provides company profile for CSL, Emergent BioSolutions, GSK, Johnson & Johnson, Pfizer, Merck, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year…
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends
Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,…
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends
Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,…
